Cargando…
The association of five preoperative serum tumor markers and pathological features in patients with breast cancer
BACKGROUND: The utility of frequently used serum tumor markers in breast cancer remains controversial. The study aimed to investigate the role of preoperative carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), cancer antigen 153 (CA153), cancer antigen 724 (CA724), and ferritin (FER) in the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595372/ https://www.ncbi.nlm.nih.gov/pubmed/30843272 http://dx.doi.org/10.1002/jcla.22875 |
_version_ | 1783430388863991808 |
---|---|
author | Lian, Mingjian Zhang, Cuixia Zhang, Dongdong Chen, Ping Yang, Huijing Yang, Yuanyuan Chen, Shidong Hong, Guolin |
author_facet | Lian, Mingjian Zhang, Cuixia Zhang, Dongdong Chen, Ping Yang, Huijing Yang, Yuanyuan Chen, Shidong Hong, Guolin |
author_sort | Lian, Mingjian |
collection | PubMed |
description | BACKGROUND: The utility of frequently used serum tumor markers in breast cancer remains controversial. The study aimed to investigate the role of preoperative carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), cancer antigen 153 (CA153), cancer antigen 724 (CA724), and ferritin (FER) in the management of breast cancer and their relationships with pathological features. METHODS: A total of 804 patients with breast mass who underwent breast surgery and 305 healthy volunteers were enrolled. Preoperative serum levels of CEA, CA125, CA153, CA724, and FER were measured. And the pathological features of all the patients were recorded. The association of preoperative serum tumor markers and pathological features was analyzed. RESULTS: Among the 804 patients, 355 were identified as malignant cases and 449 as benign cases. CEA, CA153, and FER of patients with breast cancer were higher than those of healthy volunteer group and patients with benign breast diseases. The area under curve (AUC) of CEA, CA153, and FER for distinguishing patients with breast cancer and subjects with non‐breast cancer was 0.688 (95% CI: 0.656‐0.721), 0.609 (95% CI: 0.574‐0.645), and 0.623 (95% CI: 0.586‐0.660), respectively. CA153 correlated with tumor size, node status, and TNM stage, whereas CA125 with node status. No statistic differences of the five markers were observed among the four molecular subtypes. CONCLUSION: Preoperative levels of CEA, CA153, and FER exhibit low diagnostic accuracy for breast cancer (stage I‐III). CA153 correlates with tumor burden, suggesting its prognostic value. The five serum markers do not correlate with molecular subtypes. |
format | Online Article Text |
id | pubmed-6595372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65953722019-11-12 The association of five preoperative serum tumor markers and pathological features in patients with breast cancer Lian, Mingjian Zhang, Cuixia Zhang, Dongdong Chen, Ping Yang, Huijing Yang, Yuanyuan Chen, Shidong Hong, Guolin J Clin Lab Anal Research Articles BACKGROUND: The utility of frequently used serum tumor markers in breast cancer remains controversial. The study aimed to investigate the role of preoperative carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), cancer antigen 153 (CA153), cancer antigen 724 (CA724), and ferritin (FER) in the management of breast cancer and their relationships with pathological features. METHODS: A total of 804 patients with breast mass who underwent breast surgery and 305 healthy volunteers were enrolled. Preoperative serum levels of CEA, CA125, CA153, CA724, and FER were measured. And the pathological features of all the patients were recorded. The association of preoperative serum tumor markers and pathological features was analyzed. RESULTS: Among the 804 patients, 355 were identified as malignant cases and 449 as benign cases. CEA, CA153, and FER of patients with breast cancer were higher than those of healthy volunteer group and patients with benign breast diseases. The area under curve (AUC) of CEA, CA153, and FER for distinguishing patients with breast cancer and subjects with non‐breast cancer was 0.688 (95% CI: 0.656‐0.721), 0.609 (95% CI: 0.574‐0.645), and 0.623 (95% CI: 0.586‐0.660), respectively. CA153 correlated with tumor size, node status, and TNM stage, whereas CA125 with node status. No statistic differences of the five markers were observed among the four molecular subtypes. CONCLUSION: Preoperative levels of CEA, CA153, and FER exhibit low diagnostic accuracy for breast cancer (stage I‐III). CA153 correlates with tumor burden, suggesting its prognostic value. The five serum markers do not correlate with molecular subtypes. John Wiley and Sons Inc. 2019-03-06 /pmc/articles/PMC6595372/ /pubmed/30843272 http://dx.doi.org/10.1002/jcla.22875 Text en © 2019 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Lian, Mingjian Zhang, Cuixia Zhang, Dongdong Chen, Ping Yang, Huijing Yang, Yuanyuan Chen, Shidong Hong, Guolin The association of five preoperative serum tumor markers and pathological features in patients with breast cancer |
title | The association of five preoperative serum tumor markers and pathological features in patients with breast cancer |
title_full | The association of five preoperative serum tumor markers and pathological features in patients with breast cancer |
title_fullStr | The association of five preoperative serum tumor markers and pathological features in patients with breast cancer |
title_full_unstemmed | The association of five preoperative serum tumor markers and pathological features in patients with breast cancer |
title_short | The association of five preoperative serum tumor markers and pathological features in patients with breast cancer |
title_sort | association of five preoperative serum tumor markers and pathological features in patients with breast cancer |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595372/ https://www.ncbi.nlm.nih.gov/pubmed/30843272 http://dx.doi.org/10.1002/jcla.22875 |
work_keys_str_mv | AT lianmingjian theassociationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT zhangcuixia theassociationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT zhangdongdong theassociationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT chenping theassociationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT yanghuijing theassociationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT yangyuanyuan theassociationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT chenshidong theassociationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT hongguolin theassociationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT lianmingjian associationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT zhangcuixia associationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT zhangdongdong associationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT chenping associationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT yanghuijing associationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT yangyuanyuan associationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT chenshidong associationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer AT hongguolin associationoffivepreoperativeserumtumormarkersandpathologicalfeaturesinpatientswithbreastcancer |